tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Income Statement

Compare
631 Followers

Cue Biopharma Income Statement

Last quarter (Q4 2025), Cue Biopharma's total revenue was $21.94M, an increase of 5111.88% from the same quarter last year. In Q4, Cue Biopharma's net income was $1.58M. See Cue Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 27.47M$ 9.29M$ 5.49M$ 1.25M$ 14.94M
Gross Profit
$ 23.99M$ 9.29M$ -32.61M$ 1.25M$ 16.72M
Operating Expenses
$ 50.51M$ 50.79M$ 19.54M$ 54.47M$ 60.43M
Depreciation and Amortization
$ 3.48M$ 2.35M$ 3.44M$ 1.81M$ -1.78M
EBITDA
$ -23.04M$ -37.53M$ -46.05M$ -50.49M$ -45.44M
Operating Income
$ -26.55M$ -41.50M$ -52.15M$ -53.23M$ -43.71M
Other Income/Expenses
$ 419.00K$ 826.00K$ 1.42M$ 215.00K$ 45.90K
Pretax Income
$ -26.10M$ -40.67M$ -50.73M$ -53.01M$ -43.67M
Net Income
$ -26.60M$ -40.67M$ -50.73M$ -53.01M$ -44.16M
Per Share Metrics
Basic EPS
$ -0.28$ -0.72$ -1.11$ -1.49$ -1.41
Diluted EPS
$ -0.28$ -0.72$ -1.11$ -1.49$ -1.41
Weighted Average Shares Outstanding
94.73M 56.33M 45.75M 35.65M 31.29M
Weighted Average Shares Outstanding (Diluted)
94.73M 56.33M 45.75M 35.65M 31.29M
Currency in USD

Cue Biopharma Earnings and Revenue History